This inventor holds 1 USPTO granted patent. Top assignee: Sarepta Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kunal Daud: Innovator in AAV Capsid Protein Analysis
Introduction
Kunal Daud is a prominent inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the analysis of adeno-associated virus (AAV) capsid proteins. His innovative work has the potential to advance gene therapy techniques and improve treatment options for various genetic disorders.
Latest Patents
Kunal Daud holds a patent titled "Methods for Analyzing AAV Capsid Proteins." This patent represents a crucial step in understanding the structural and functional properties of AAV, which is essential for the development of effective gene therapies. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.
Career Highlights
Kunal Daud is currently employed at Sarepta Therapeutics, Inc., a leading company in the field of genetic medicine. His role at Sarepta allows him to work on cutting-edge research and collaborate with other experts in the industry. His contributions are vital to the company's mission of developing transformative therapies for patients with serious diseases.
Collaborations
Kunal has collaborated with notable colleagues, including Ju Li and Uditha Dealwis. These partnerships enhance the research environment and foster innovation within the team.
Conclusion
Kunal Daud is an influential inventor whose work in AAV capsid protein analysis is paving the way for advancements in gene therapy. His dedication to research and collaboration with esteemed colleagues positions him as a key figure in the biotechnology sector.